Teriparatide Injection, Solution
Product Images NDC 60505-6188

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Teriparatide (NDC 60505-6188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Caption-1 (Caption 1)

FDA Label Image

Carton-label (Carton Label)

FDA Label Image

Figure-1 (Figure 1)

FDA Label Image

Figure-10 (Figure 10)

FDA Label Image

Figure-11 (Figure 11)

FDA Label Image

Figure-12 (Figure 12)

FDA Label Image

Figure-13 (Figure 13)

FDA Label Image

Figure-14 (Figure 14)

FDA Label Image

Figure-15 (Figure 15)

FDA Label Image

Figure-16 (Figure 16)

FDA Label Image

Figure-17 (Figure 17)

FDA Label Image

Caption-2 (Figure 19)

FDA Label Image

Figure-2 (Figure 2)

FDA Label Image

Figure-3 (Figure 3)

FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
Pull off paper tab is a short instruction indicating that there is a tab on a piece of paper that can be removed. This could be relevant for various scenarios such as opening a package, activating a device, or revealing information or details hidden beneath the tab.*
FDA Label Image

Figure-5 (Figure 5)

FDA Label Image

Figure-6 (Figure 6)

FDA Label Image

Figure-7 (Figure 7)

FDA Label Image

Figure-8 (Figure 8)

FDA Label Image

Figure-9 (Figure 9)

FDA Label Image

Injection-label (Injection Label)

Injection-label (Injection Label)
Teriparatide Injection, USP is a medication that is administered subcutaneously once daily. Each dose contains 20 meg and is provided in a single-patient-use prefilled pen. The pen can deliver 28 subcutaneous doses in total. The concentration of the medication is 600 mcg/2.4 mL (250 meg/mL). It is important to not transfer the contents of the pen to a syringe and to read the User Manual before injecting. The medication should be refrigerated and not frozen. After the first use, the pen should be discarded after 28 days. This specific product is marketed by Apotex Corp, which is located in Weston, Florida. The product is manufactured in Canada.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.